Navigation Links
IRIDEX Reports 2011 Fourth Quarter and Year-End Results
Date:3/1/2012

MOUNTAIN VIEW, Calif., March 1, 2012 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the fourth quarter ended December 31, 2011. Due to the sale of the Company's aesthetics laser business in February 2012, the Company will be reporting its results for its continuing ophthalmology business.  

  • Revenues from ophthalmology were $8.6 million in the fourth quarter of 2011, up sequentially from $8.3 million in the third quarter of 2011, and down from $9.0 million in the prior year period. Total sales from continuing operations for the year increased to $33.2 million, up from $32.3 million.
  • For the fourth quarter of 2011, income from continuing operations was $0.8 million or $0.08 per diluted share, up sequentially from $0.3 million or $0.02 per diluted share in the third quarter of 2011, and up from $0.2 million or $0.02 per diluted share reported in the fourth quarter of 2010. The fourth quarter of 2011 includes a credit of $1.3 million to operating expenses and $0.3 million of other expense representing the impact of the settlement and distribution agreement signed in November with Alcon.
  • For the full-year 2011, income from continuing operations was $2.1 million or $0.21 per diluted share, compared to $1.7 million or $0.16 per diluted share reported in the full-year 2010. The full-year 2011 includes a credit of $1.3 million to operating expenses and $0.3 million of other expense representing the impact of the agreements with Alcon.

  • President and CEO Dominik Beck said, "The turn of the year 2011/12 marked the culmination of a period of intense business development and market activity as we executed on a number of key elements of our strategic plan.  By selling our aesthetics laser business, we can now focus solely on our ophthalmology business. By entering into a distribution agreement with Alcon we have
    '/>"/>

    SOURCE IRIDEX Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11

    Related medicine technology :

    1. IRIDEX Announces Fourth Quarter and Full Year 2011 Conference Call and Release Date
    2. IRIDEX MicroPulse™ Laser Therapy Enhances Visual Function in Patients with Central Serous Chorioretinopathy (CSC)
    3. IRIDEX to Present at the Sidoti & Company New York Micro Cap Conference
    4. Cutera and IRIDEX Announce Acquisition of IRIDEX Aesthetic Business Unit
    5. 10-Year Study Demonstrates IRIDEX MicroPulse™ Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema
    6. IRIDEX Signs License and Distribution Agreement with Leader in Eye Care
    7. IRIDEX Reports 2011 Third Quarter and Nine-Month Results
    8. IRIDEX Announces Third Quarter 2011 Conference Call and Release Date
    9. IRIDEX Launches New MicroPulse™ Module Targeting the Broad Ophthalmology Laser Photocoagulation Market
    10. IRIDEX Names Veteran Healthcare Executive Dominik Beck President, CEO
    11. IRIDEX Licenses the Exclusive Rights to Ophthalmology Products and Intellectual Property from Ocunetics, Inc.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2015)... , May 20, 2015 Research ... of the "Guide to Prepare Application Dossiers ... China (2014 Edition) " report to their ... is one of segment market of the most ... overseas medical device manufacturers and producers to penetrate ...
    (Date:5/22/2015)... , May 22, 2015 ... phase clinical research unit with a worldwide reputation ... for its frequent publications in peer reviewed medical ... European stakeholders and regulators in discussions about rules ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , ...
    (Date:5/21/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/jx648d/north_american ... "North American Active Wound Care Market by Method ... Ulcer), by End-User (In-Patient, & Out-Paient) - Analysis ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The North American ... at a CAGR of 3.1% from 2014 to ...
    Breaking Medicine Technology:China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2
    ... Feb. 3, 2012 Boehringer Ingelheim presented results ... (aspirin/extended-release dipyridamole), an antiplatelet medication, is not affected ... inhibitor (PPI), frequently used to treat several gastrointestinal ... Stroke Conference (ISC) in New Orleans. ...
    ... response to investment community speculation following release of the ... Lidoderm ® patent challenge, Watson Pharmaceuticals, Inc. (NYSE: ... "Watson,s abbreviated new drug application (ANDA) for ... believe questions related to the site where a biostudy ...
    Cached Medicine Technology:Study Finds No Drug-Drug Interaction Between Aggrenox® (aspirin/extended-release dipyridamole) 25mg/200mg Capsules and Omeprazole, a Widely Used PPI 2Study Finds No Drug-Drug Interaction Between Aggrenox® (aspirin/extended-release dipyridamole) 25mg/200mg Capsules and Omeprazole, a Widely Used PPI 3Watson Provides Update on Generic Lidoderm® Application 2Watson Provides Update on Generic Lidoderm® Application 3
    (Date:5/25/2015)... May 25, 2015 Tunstall Americas announces ... the highest level of service to its Medical Answering ... and a restructuring of resources, Tunstall now provides a ... the Medical Answering Service to ensure superior patient satisfaction. ... it has invested over $10 million in expanded facilities ...
    (Date:5/24/2015)... The Rolling Stones Zip Code ... Diego at Petco Park. This iconic group is ready ... 20th, they had a warmup show in Los Angeles at ... Los Angeles, this beloved band not only played their Sticky ... such as "Jumping Jack Flash," "Moonlight Mile" and "All ...
    (Date:5/24/2015)... (PRWEB) May 24, 2015 Scientists with ... paper on air quality compliance issues that may have ... workers. Surviving Mesothelioma has just posted an article on ... , The group found airborne asbestos levels well ... collected between 1984 and 2011. , “Asbestos compliance sampling ...
    (Date:5/24/2015)... Indiana Fiber Network, LLC (IFN), the leading Indiana ... Inc. (MTA) has selected IFN as a fiber transport ... Sales Manager, fiber route diversity and network redundancy are ... MTA with the diverse fiber transport from their Merrillville ... voice carriers located at Henry Street in Indianapolis, IN. ...
    (Date:5/23/2015)... (PRWEB) May 23, 2015 On Saturday, May ... a new playground for Branches Florida City exactly five years ... play space in 2010. , A large fire tore through ... on May 23, 2010 in the middle of the night ... fire was later declared arson even though it is suspected ...
    Breaking Medicine News(10 mins):Health News:Tunstall Introduces New Medical Answering Service for the 21st Century Practice 2Health News:The Rolling Stones Tickets in San Diego, Orlando, Minneapolis, Dallas, Pittsburgh, Indianapolis, Atlanta, Detroit, Milwaukee, Kansas City, Columbus, Nashville & Raleigh 2Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Five Years After Fire, Branches Rebuilds Playground 2
    ... to Ongoing Oncology Program for MDX-1106, PRINCETON, ... Medarex, Inc. (Nasdaq: MEDX ) announced today ... filed with the U.S. Food &,Drug Administration (FDA) ... Ltd.), a fully human anti-PD-1 antibody being,investigated for ...
    ... Cardiac Science,Corporation (Nasdaq: CSCX ), a global ... today that it will present at the,18th Annual ... City. The,Company,s presentation is scheduled for Monday, November ... president and chief executive officer, will,review the Company,s ...
    ... loss (specifically peripheral visual fields) is the primary ... according to a study published this month in ... publication of the Association for Research in Vision ... "Visual Field Loss Increases the Risk of Falls ...
    ... Cup Being Replaced, No Issue with Medicine -, ... of Wyeth (NYSE: WYE ), today announced it ... U.S. retail,outlets that sell several Robitussin(R) products and Children,s ... existing products,with a dosage cup that does not have ...
    ... organizations support shift from exclusively genetic model to,environmental ... Institute of,Medicine (IOM) last Friday released a report ... demonstrating a marked shift in the research,agenda from ... of autism. The National Autism Association (NAA) and ...
    ... Md., Oct. 29 BioReliance Corporation today,appointed its ... post of Interim CEO, following the announced resignation ... BioReliance announced that,three senior executives have joined the ... Scientific Officer, David S. Walker as Chief,Financial Officer, ...
    Cached Medicine News:Health News:Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody 2Health News:Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody 3Health News:Ono and Medarex Announce Allowance of Investigational New Drug Application for Fully Human Anti-PD1 Antibody 4Health News:Cardiac Science to Present at the 18th Annual CIBC World Markets Healthcare Conference 2Health News:Visual field loss primary component in risk of falls for older adults 2Health News:Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Children's Dimetapp Cold & Chest Congestion 2Health News:Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Children's Dimetapp Cold & Chest Congestion 3Health News:IOM Workshop Calls for Greater Research Focus on Environmental Causes of Autism 2Health News:BioReliance Appoints Executive Chairman to be Interim CEO and Announces Recent Senior Executive Additions 2Health News:BioReliance Appoints Executive Chairman to be Interim CEO and Announces Recent Senior Executive Additions 3
    ... concave seats and large backrests with ... seats, backrests, armrests, and casters and ... for top performance in a variety ... clean room, static control, health care ...
    ... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... the BE Series for top performance ... industry, education, laboratory, clean room, static ...
    ... Durable ergonomic chairs with concave seats and ... options like seats, backrests, armrests, and casters ... for top performance in a variety of ... static control, health care and office. • ...
    ... Durable ergonomic chairs with concave seats ... Select options like seats, backrests, armrests, and ... Series for top performance in a variety ... room, static control, health care and office. ...
    Medicine Products: